A study to assess changes in inferior vena cava size in patients with heart failure
- Conditions
- Health Condition 1: I509- Heart failure, unspecified
- Registration Number
- CTRI/2019/07/020074
- Lead Sponsor
- Fire
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1- Adults 18 years of age or older with NYHA Class III heart failure with any of the following in the past 12 months: a decompensation due to heart failure, heart failure treatment in a hospital day care setting or urgent outpatient heart failure visit
2- On a diuretic for the management of heart failure
3- IVC must be well visualized via Ultrasound, that is assessment of the full circumference of the IVC visible without any ambiguity
4- Written informed consent
1- Patients that have had deterioration in symptoms of have had a hospital admission in the previous 30 days.
2- Patients with echocardiographic evidence of severe tricupsid regurgitation
3- Significant comorbidity that would interfere with the ability to safety complete the study protocol.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To examine the normal variability of the IVC geometry in a stable group of heart failure patients. <br/ ><br> <br/ ><br>Timepoint: IVC size variability over 28 days of study period
- Secondary Outcome Measures
Name Time Method 1.IVC area (A max and A Min) <br/ ><br>2.IVC area collapsibility <br/ ><br>3.Cardiac collapsibility and rate <br/ ><br>4.Respiration rate <br/ ><br>Timepoint: IVC size variability over 28 days of study period